Icaritin downregulates the mRNA and protein expression of PD-L1 in liver cancer (SMMC-7721) and melanoma (B16-F10) cells, enhancing anti-cancer immune responses and prolonging patient survival [699, 711, 712]. This evidence concerns the gene CD274 and liver cancer.